Microbiome Labs has launched EpicDefense on Amazon, a new microbiome-based supplement designed to support the body's natural immune defenses and promote respiratory comfort. The formula includes clinically studied probiotic strains and nutrients like LGG, BB-12, EpiCor®, and zinc bisglycinate to enhance immune balance and respiratory health. This product emphasizes proactive, gut-powered immune resilience rather than reactive supplementation and meets high standards by being non-GMO, soy-free, and dairy-free. The launch reflects Microbiome Labs' commitment to translating microbiome research into accessible, science-backed health solutions.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Ethereum (ETH) has outperformed Bitcoin (BTC) in Q3, driven by a rally sparked by a softer CPI report and strong on-chain metrics. The recent surge pushed ETH above $1,900, triggering significant liquidations in futures positions. However, ETH now fa...
Solana's number of wallets holding tokenized real-world assets (RWAs) has exceeded 300,000, surpassing Ethereum's roughly 200,000 holders. While Solana's RWA value doubled in 2026 to $3.45 billion, Ethereum still leads with $16.3 billion in tokenized...
Baidu's board has approved a plan to convert to a dual-primary listing on the Hong Kong Stock Exchange's Main Board, alongside its existing Nasdaq listing. This move aims to enhance the liquidity of Baidu's shares, broaden its investor base, and prov...
